Skip to main content
Premium Trial:

Request an Annual Quote

WRI Joins BioServe's Biospecimen Network

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Windber Research Institute will join BioServe's biospecimen network under an agreement announced today.

BioServe said that it will supplement its clinical-grade biospecimens in its Global BioRepository with biosamples from WRI's Tissue Bank, which includes cancer specimens and non-disease tissues. Biospecimens collected and stored by WRI include plasma, serum, tissue embedded in optimum cutting temperature, formalin-fixed paraffin-embedded tissue, and flash frozen tissue.

Terms of the agreement were not disclosed.

Earlier this month, BioServe announced it was supplementing its Global BioRepository with biospecimen samples from the University of Massachusetts Medical School's Cancer Center Tissue Bank.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.